IFBB Pro Champion Anton Antipov Hosts Podcast with Dr. Brian Mehling
On August 2nd, 2019 IFBB Pro Champion and professional fitness model Anton Antipov hosts the podcast Gee Talks, and recently had Dr. Brian Mehling on as a guest to have a long, wide-ranging discussion about the potential of stem cell science. Antipov has received three stem cell treatments from Dr. Mehling, once in the BHI clinic in Bratislava, Slovakia, and twice in the new Montego Bay, Jamaica clinic, and intends to receive...
read moreLiving Cells
Live stems cells and primary cells. these images are slices from a 3D hologram made by recording cell density and there is no labelling from LivingCells Live stem cells and primary cells
read moreBHI Ambassador and PFL Featherweight Champion Lance Palmer endorses stem cell therapy in BHI Jamaica
Lance Palmer is a featherweight MMA champion who credits stem cell treatments from BHI with a greater feeling of better overall health, more energy, and help with the training recovery process. Mr. Palmer is a former amateur wrestler and current mixed martial arts fighter. He competes for the Professional Fighters League in the Featherweight division. A four-time NCAA All-American, Mr. Palmer was a member of the Ohio State wrestling team. Mr. Palmer recently won a fight on July 25, 2019 at...
read moreBHl Rejuve attends The Europa Games Nutrition & Wellness Expo
BHI Rejuve, a hormone optimization program, exhibited at the Europa Games Nutrition & Wellness Expo in Dallas on June 8-9, 2019. Attendees of the conference include individuals who are eager to learn more about improving their quality of life. More than 8,000 wellness enthusiast and professional bodybuilders, competing for their “International Federation of Body Builders (IFBB)” professional cards, attended the two-day event. Representatives from BHI Rejuve presented information on its hormone optimization program...
read moreDr. Brian Mehling presents in Monaco
Brian Mehling, MD, and Michael Kelly, MD had a successful presentation at the Princess Grace Hospital Monaco in Monte Carlo, France. Dr. Brian Mehling’s presentation was focused on BHI Therapeutic Sciences (BHITS) stem cell research studies. It included BHITS stem cell therapy methods, results of Institutional Review Board approved stem cell research studies, resent advances in BHITS stem cell research (Presentation at the American Academy of Orthopedic Surgeons Annual Meeting, New Orleans, Louisiana, 2018 and Presentation at the conference...
read moreBHI Therapeutic Sciences studies are registered at the clinical trial registries
Clinical trials are research investigations that play an important role in the development of health information and research for public health care. Clinical trials guiding principles are based on maximum benefit and minimal risk to the participants enrolled in a study. According to the Ethical Principles for Medical Research Involving Human Subjects (World Medical Association Declaration of Helsinki), “every clinical trial must be registered in a publicly accessible database before recruitment of first subject”. The main registry...
read moreBHI THERAPEUTIC SCIENCES ABSTRACT TO BE PRESENTED AT GERMAN STEM CELL CONFERENCE
BHI Therapeutic Sciences (BHITS) has been invited to present its abstract, “A retrospective chart review study of allogeneic umbilical cord blood mononuclear cell therapy for stroke,” at the German Stem Cell Network;s 7th Annual GSCN Conference being held Sept. 23-25 at the Max Delbruck Center for Molecular Medicine in Berlin. Marina Manvelyan, PhD., BHITS Clinical Research Scientist said: “We are excited to be part of this gathering to share knowledge with other scientists across the globe. We look...
read moreBHI Therapeutic Sciences Inc. Notified by FDA that is can proceed with New Drug Clinical Trial for Acute Ischemic Stroke
BHI Therapeutic Sciences (BHITS), a leader in stem cell therapy and research utilizing human umbilical cord blood, announced today that the company has been notified by the Food and Drug Administration (FDA) that its Investigational New Drug (IND) application to allow for the initiation of a clinical study of an FDA-approved cell therapy (HCP, cord blood) for treatment of acute ischemic stroke may proceed. Phase 1/2 Study entitled “Evaluation of the Safety and Efficacy of Hemacord HPC, Cord Blood in Subjects with Acute Ischemic...
read moreProfessional Physique Champion is named Ambassador for BHI Slovakia.
Anton Antipov, an International Federation of Body Building and Fitness (IFBB) professional physique champion and fitness model, recently visited BHI Slovakia, stem cell research and treatment center, where he was named an ambassador for the healthcare organization. Mr. Antipov is an accomplished competitor and New York-based model, who has made a name for himself on social media and in the fitness industry. Growing up in Belarus, Mr. Antipov never had access to a gym, but he played sports to stay fit. After his family immigrated to America...
read moreStem Cells: The Next Frontier documentary screening for investors in NYC.
BHI Therapeutic Sciences (BHITS) and Brian Mehling, M.D. hosted a private screening of Stem Cells: The Next Frontier on Tuesday, February 13 in New York. The evening included a Q & A session and information on how to participate by becoming an investor to make these life-saving stem cells therapies more accessible to patients across the globe. “At BHITS, our philosophy is that stem cells are the future of medicine and we are excited to share our ideas with the general public and investors. BHITS is pioneering ethical, effective, safe...
read more
